Literature DB >> 27686880

Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.

Hong-Xin Peng1,2, Lin Yang1, Bang-Shun He2, Yu-Qin Pan2, Hou-Qun Ying3, Hui-Ling Sun2, Kang Lin2, Xiu-Xiu Hu1,2, Tao Xu2, Shu-Kui Wang1,2.   

Abstract

BACKGROUND: Inflammation plays an important role in the development and progression of CRC. The members of inflammatory biomarkers, preoperative NLR and PLR, have been proved by numerous studies to be promising prognostic biomarkers for CRC. However, the diagnostic value of the two biomarkers in CRC remains unknown, and no study reported the combined diagnostic efficacy of NLR, PLR and CEA.
METHODS: Five hundred and fifty-nine patients with I-III stage CRC undergoing surgical resection and 559 gender- and age-matched healthy controls were enrolled in this retrospective study. NLR and PLR were calculated from preoperative peripheral blood cell count detected using white blood cell five classification by Sysmex XT-1800i Automated Hematology System and serum CEA were measured by electrochemiluminescence by ELECSYS 2010. The diagnostic performance of NLR, PLR and CEA for CRC was evaluated by ROC curve.
RESULTS: Levels of NLR and PLR in the cases were significantly higher than them in the healthy controls. ROC curves comparison analyses showed that the diagnostic efficacy of NLR (AUC=.755, 95%CI=.728-.780) alone for CRC was significantly higher than PLR (AUC=.723, 95%CI=.696-.749, P=.037) and CEA (AUC=.690, 95%CI=.662-.717, P=.002) alone. In addition, the diagnostic efficacy of the combination of NLR, PLR and CEA(AUC=.831, 95%CI=.807-.852)for CRC was not only significantly higher than NLR alone but also higher than any combinations of the two of these three biomarkers (P<.05). Moreover, the NLR and PLR in the patients with TNM stage I/II was higher than that in the healthy controls, and patients with stage III had a higher NLR and PLR than those with stage I/II, but no significant difference was observed.
CONCLUSION: Our study indicated that preoperative NLR could be a CRC diagnostic biomarker, even for early stage CRC, and the combination of NLR, PLR and CEA could significantly improve the diagnostic efficacy.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; diagnosis; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio

Mesh:

Substances:

Year:  2016        PMID: 27686880      PMCID: PMC6816914          DOI: 10.1002/jcla.22075

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  34 in total

Review 1.  Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.

Authors:  Mu-Xing Li; Xue-Min Liu; Xu-Feng Zhang; Jian-Fei Zhang; Wan-Li Wang; Ying Zhu; Jian Dong; Ji-Wen Cheng; Zheng-Wen Liu; Le Ma; Yi Lv
Journal:  Int J Cancer       Date:  2014-01-29       Impact factor: 7.396

2.  Relationship between colonic polyp type and the neutrophil/ lymphocyte ratio as a biomarker.

Authors:  Hatice Karaman; Ahmet Karaman; Abdulsamet Erden; Orhan Kursat Poyrazoglu; Cigdem Karakukcu; Arzu Tasdemir
Journal:  Asian Pac J Cancer Prev       Date:  2013

3.  Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.

Authors:  Jing Jia; Xiongwei Zheng; Ying Chen; Lin Wang; Lu Lin; Xingming Ye; Yan Chen; Dedong Chen; Markus Dettke
Journal:  Tumour Biol       Date:  2015-06-25

Review 4.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.

Authors:  Steven H Itzkowitz; Xianyang Yio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07       Impact factor: 4.052

5.  Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils.

Authors:  R Appelberg
Journal:  J Leukoc Biol       Date:  1992-05       Impact factor: 4.962

6.  Rapid diagnosis of pancreatic cancer by combination of ultrasonography and serum tumour markers CA 19-9 and CA 50.

Authors:  P Bovo; L Rigo; M Togni; G Montesi; V Di Francesco; M P Brunori; G Angelini; L Frulloni; M Marcori; G Cavallini
Journal:  Ital J Gastroenterol       Date:  1993 Nov-Dec

7.  Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.

Authors:  Yaqi Li; Huixun Jia; Wencheng Yu; Ye Xu; Xinxiang Li; Qingguo Li; Sanjun Cai
Journal:  Int J Cancer       Date:  2016-03-18       Impact factor: 7.396

8.  Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma.

Authors:  Serta Kilincalp; Şahin Çoban; Hakan Akinci; Mevlüt Hamamcı; Fatih Karaahmet; Yusuf Coşkun; Yusuf Üstün; Zahide Şimşek; Elife Erarslan; İlhami Yüksel
Journal:  Eur J Cancer Prev       Date:  2015-07       Impact factor: 2.497

9.  Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.

Authors:  Z-Y Chen; K Raghav; C H Lieu; Z-Q Jiang; C Eng; J-N Vauthey; G J Chang; W Qiao; J Morris; D Hong; P Hoff; H Tran; D G Menter; J Heymach; M Overman; S Kopetz
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

10.  Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; W J Angerson; D J Dunlop
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more
  22 in total

1.  Clinical values of circular RNA 0000181 in the screening of gastric cancer.

Authors:  Qianfu Zhao; Shijun Chen; Tianwen Li; Bingxiu Xiao; Xinjun Zhang
Journal:  J Clin Lab Anal       Date:  2017-09-22       Impact factor: 2.352

2.  Significant association of PRMT6 hypomethylation with colorectal cancer.

Authors:  Ranran Pan; Hang Yu; Jie Dai; Cong Zhou; Xiuru Ying; Jie Zhong; Jun Zhao; Yihan Zhang; Boyi Wu; Yiyi Mao; Dongping Wu; Jieer Ying; Shiwei Duan
Journal:  J Clin Lab Anal       Date:  2018-06-21       Impact factor: 2.352

3.  Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer.

Authors:  Maria Hernandez-Ainsa; Raul Velamazan; Angel Lanas; Patricia Carrera-Lasfuentes; Elena Piazuelo
Journal:  Front Med (Lausanne)       Date:  2022-06-20

4.  Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

Authors:  Lin Yang; Wenzhuo He; Pengfei Kong; Chang Jiang; Qiong Yang; Qiankun Xie; Liang Ping Xia
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

5.  Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.

Authors:  Yuanyuan Tang; Shusuan Jiang; Yinmin Gu; Weidong Li; Zengnan Mo; Yuanjie Huang; Tianyu Li; Yanling Hu
Journal:  Oncotarget       Date:  2017-03-22

6.  Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese.

Authors:  Ranran Pan; Cong Zhou; Jie Dai; Xiuru Ying; Hang Yu; Jie Zhong; Yihan Zhang; Boyi Wu; Yiyi Mao; Dongping Wu; Jieer Ying; Wei Zhang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2018-10-12       Impact factor: 2.447

7.  Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis.

Authors:  Hyunjung Kim; Hae Il Jung; Soon Ha Kwon; Sang Ho Bae; Hyung Chul Kim; Moo-Jun Baek; Moon Soo Lee
Journal:  Ann Surg Treat Res       Date:  2019-03-28       Impact factor: 1.859

8.  Expression profiles of circular RNAs in human colorectal cancer based on RNA deep sequencing.

Authors:  Jiaxin Ge; Yanping Jin; Xueyou Lv; Qi Liao; Cong Luo; Guoliang Ye; Xinjun Zhang
Journal:  J Clin Lab Anal       Date:  2019-06-06       Impact factor: 2.352

9.  Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer.

Authors:  Milica Stojkovic Lalosevic; Aleksandra Pavlovic Markovic; Sanja Stankovic; Mirjana Stojkovic; Ivan Dimitrijevic; Irena Radoman Vujacic; Daria Lalic; Tamara Milovanovic; Igor Dumic; Zoran Krivokapic
Journal:  Dis Markers       Date:  2019-01-17       Impact factor: 3.434

10.  Diagnostic value of derived neutrophil-to-lymphocyte ratio in patients with ovarian cancer.

Authors:  Yang-Yang Wu; Yuan-Yuan Qin; Jin-Qiu Qin; Xuan Zhang; Fa-Quan Lin
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.